Skip to main content

Table 2 Distribution of histological classification and gender in patients with T2DM and lung cancer

From: Discovery and validation of PZP as a novel serum biomarker for screening lung adenocarcinoma in type 2 diabetes mellitus patients

Histological classifications Age Gender Total Proportion
Male Female
Adenocarcinoma 66.74 ± 8.17 256 62.29% 155 37.71% 411 60.62%
Squamous carcinoma 65.89 ± 8.27 61 64.89% 33 35.11% 94 13.86%
Small cell carcinoma 65.80 ± 7.05 15 60.00% 10 40.00% 25 3.69%
Mixed carcinoma 66.20 ± 6.75 8 80.00% 2 20.00% 10 1.47%
Neuroendocrine carcinoma 67.17 ± 7.49 4 66.67% 2 33.33% 6 0.88%
Magnocellular carcinoma 69.00 ± 5.66 2 100.00% 0 0.00% 2 0.29%
Other 68.67 ± 7.15 6 100.00% 0 0.00% 6 0.88%
Unknown 67.05 ± 9.57 96 77.42% 28 22.58% 124 18.29%
Total 66.66 ± 8.36 448 66.08% 230 33.92% 678 100.00%
\